Antigenics Inc ANTI
$0.00
Last Updated: May 14, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
A
Antigenics Inc. Stock Analysis ANTI
United States N/A Nano Cap Antigenics, Inc. (Pennsylvania) engages in the development of pharmaceutical products for cancer treatment. The company is headquartered in Horsham, Pennsylvania and currently employs 29 full-time employees. The company went IPO on 2001-07-18. The firm is developing a series of checkpoint modulators (CPM) for the treatment of patients with cancer, infectious diseases, and other immune disorders; heat shock protein (HSP)-based vaccines, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Retrocyte Display (Retroviral B Lymphocyte Display) is an antibody discovery platform designed for the discovery and optimization of fully human and humanized monoclonal antibodies against an array of molecular targets. Its HSP-based vaccine platform includes its Prophage Series vaccine candidates for the treatment of cancer and its HerpV vaccine candidate for the treatment of genital herpes. Its pipeline of product candidates containing QS-21 Stimulon includes vaccines for infectious diseases, cancer types and Alzheimer's disease.
Antigenics Inc (ANTI) Chart
Financial Metrics & Statements of Antigenics Inc (ANTI)
FAQ's for Antigenics Inc (ANTI)
- As of August 2026, Antigenics Inc ANTI is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Antigenics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Antigenics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Antigenics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Antigenics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Antigenics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Antigenics Inc (ANTI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
